Ketamine has been used for more than 50 years as an intravenous anesthetic but has
had a recent resurgence in the perioperative pain period as a multimodal adjunct.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in AnesthesiaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581.Anesth Analg. 1966; 45: 29-40
- Pharmacologic effects of CI-581, a new dissociative anesthetic, in man.Clin Pharmacol Ther. 1965; 6: 279-291
- History and pharmacology of PCP and PCP-related analogs.J Psychedelic Drugs. 1980; 12: 223-227
- Ketamine—a revolutionary anesthetic agent for the battle casualty.Plast Reconstr Surg. 1974; 53: 615
- Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018; 43: 456-466
- Expanding Role of NMDA Receptor Antagonists in the Management of Pain.CNS Drugs. 2019; 33: 347-374
- Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug.J Clin Pharmacol. 2009; 49: 957-964
- Metabolism and metabolomics of ketamine: a toxicological approach.Forensic Sci Res. 2017; 2: 2-10
- Ketamine for the Prevention of Posttraumatic Stress Disorder in Burned Patients.J Burn Care Res. 2017; 38: e690
- An update on the basic and clinical science of ketamine analgesia.Clin J Pain. 2018; 34: 1077-1088
- Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms.Pharmacol Rev. 2018; 70: 621-660
- Ketamine use in current clinical practice.Acta Pharmacol Sin. 2016; 37: 865-872
- Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study.J Pain Res. 2017; 10: 787
- The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review.Ann Emerg Med. 2015; 65: 43-51.e2
- Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Reg Anesth Pain Med. 2018; 43: 521-546
- In vogue: ketamine for neuroprotection in acute neurologic injury.Anesth Analg. 2017; 124: 1237-1243
- A Systematic Review and Meta-analysis of Ketamine as an Alternative to Opioids for Acute Pain in the Emergency Department.Acad Emerg Med. 2018; 25: 1086-1097
- Efficacy and safety of morphine and low dose ketamine for pain control of patients with long bone fractures: a randomized, double-blind, clinical trial.Bull Emerg Trauma. 2018; 6: 31
- Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.Pain. 2009; 145: 304-311
- Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial.Pain Physician. 2010; 13: 245-249
- A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial.Pain. 2002; 97: 275-281
- Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials.Anesth Analg. 2019; 129: 241-254
- A consensus statement on the use of ketamine in the treatment of mood disorders.JAMA psychiatry. 2017; 74: 399-405
- Ketamine with and without midazolam for emergency department sedation in adults: a randomized controlled trial.Ann Emerg Med. 2011; 57: 109-114.e2
- Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study.Pain. 2009; 147: 107-115
- Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy.Clin Pharmacokinet. 2016; 55: 1059-1077
- Oral ketamine for the treatment of pain and treatment-resistant depression.Br J Psychiatry. 2016; 208: 108-113
- Analgesic effects of topical ketamine.Minerva Anestesiol. 2015; 81: 440-449
- Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis.Pain Med. 2012; 13: 263-269
- Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU.Crit Care Med. 2018; 46: e825-e873
- Benzodiazepine-associated delirium in critically ill adults.Intensive Care Med. 2015; 41: 2130-2137
- Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.Jama. 2012; 307: 1151-1160
- Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis.Anesth Analg. 2012; 115: 934-943
- Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery.Acta Anaesthesiol Scand. 2009; 53: 864-872
- Assessment of non-technical skills in the operating room--one assessment tool per specialty?.Acta Anaesthesiol Scand. 2014; 58: 773
- Ketamine sedation in mechanically ventilated patients: A systematic review and meta-analysis.J Crit Care. 2020; 56: 80-88
- The ketamine effect on ICP in traumatic brain injury.Neurocrit Care. 2014; 21: 163-173
- Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation.Anesthesiology. 1997; 87: 1328-1334
- Adverse reactions to ketamine anaesthesia: abolition by a psychological technique.Anaesthesia. 1981; 36: 183-187
- Acute macular outer retinopathy (AMOR): a reappraisal of acute macular neuroretinopathy using multimodality diagnostic testing.Arch Ophthalmol. 2011; 129: 360-371
- Intravenous sub-anesthetic ketamine for perioperative analgesia.J Anaesthesiol Clin Pharmacol. 2016; 32: 160
- A systematic review of intravenous ketamine for postoperative analgesia.Can J Anesth. 2011; 58: 911
- Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial.Lancet. 2017; 390: 267-275
- Opioid-induced hyperalgesiaA qualitative systematic review.Anesthesiology. 2006; 104: 570-587
- The scale of the evidence base on the health effects of conventional yogurt consumption: findings of a scoping review.Front Pharmacol. 2015; 6: 246
- Ketamine and depression: a narrative review.Drug Des Dev Ther. 2019; 13: 3051
- Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗ D: implications for clinical practice.Am J Psychiatry. 2006; 163: 28-40
- Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.Depress Anxiety. 2014; 31: 291-296
- Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.Neuropharmacology. 2012; 62: 63-77
- A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats.Anesthesiology. 2011; 115: 812-821
- A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.Mol Psychiatry. 2016; 21: 320
- Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?.J Clin Psychiatry. 2017; 78: e852-e857
- Antidepressant effects of ketamine in depressed patients.Biol Psychiatry. 2000; 47: 351-354
- A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.Arch Gen Psychiatry. 2006; 63: 856-864
- Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.Biol Psychiatry. 2010; 67: 139-145
- On the safety and benefits of repeated intravenous injections of ketamine for depression.Biol Psychiatry. 2012; 72: e11-e12
- Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.Biol Psychiatry. 2013; 74: 250-256
- Acute antidepressant effects of intramuscular versus intravenous ketamine.Indian J Psychol Med. 2014; 36: 71
- A randomized controlled trial of intranasal ketamine in major depressive disorder.Biol Psychiatry. 2014; 76: 970-976
Fala L. Spravato (Esketamine) Nasal Spray First NMDA Receptor Antagonist Approved by the FDA for Adults with Treatment-Resistant Depression. Available at: http://www.ahdbonline.com/issues/2019/2019-payers-guide-mid-year-addendum/2809-spravato-esketamine-nasal-spray-first-nmda-receptor-antagonist-approved-by-the-fda-for-adults-with-treatment-resistant-depression.
- Acute and chronic effects of ketamine upon human memory: a review.Psychopharmacology (Berl). 2006; 188: 408-424
- Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder.J affective Disord. 2019; 246: 241-247
- Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.Neuropsychopharmacology. 2015; 40: 1084-1090
- Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis.Biol Psychiatry. 2010; 68: 568-577
Article info
Publication history
Published online: September 14, 2020
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
